ZMYND8

MYND-type zinc finger-containing chromatin reader ZMYND8 · Q9ULU4 · ZMYND8 on Sugi Atlas →

0 patent compounds predicted against ZMYND8, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ZMYND8 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients PHASE3UNKNOWN
Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome PHASE3UNKNOWN
Study of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) PHASE2ACTIVE_NOT_RECRUITING
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma PHASE1/PHASE2COMPLETED
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure PHASE2COMPLETED
5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS PHASE2COMPLETED
Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma PHASE2WITHDRAWN
Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma PHASE2SUSPENDED
Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load PHASE1COMPLETED
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma PHASE1UNKNOWN
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
Pracinostat and Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia PHASE1COMPLETED
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Exploiting Epigenome Editing in Kabuki Syndrome: a New Route Towards Gene Therapy for Rare Genetic Disorders nanCOMPLETED
Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells. nanUNKNOWN
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia nanCOMPLETED
X-chromosome Inactivation, Epigenetics and the Transcriptome nanCOMPLETED
CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma nanUNKNOWN
Patients With RETT Syndrome nanUNKNOWN
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies nanWITHDRAWN
COPENHAGEN Minipuberty Study nanUNKNOWN
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Methylation of DNA in Children and Adolescents With Type 1 Diabetes Mellitus (METHYLDIAB) nanCOMPLETED
PCM1-JAK2 in Therapy Related Neoplasms nanUNKNOWN
Clinical and Genomic Registry of MDS in Asia nanUNKNOWN
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a ZMYND8 binder may also engage these)

ProteinNameSimilarity
BPTF Nucleosome-remodeling factor subunit BPTF 0.999 landscape →
Q92539 0.997 Q92539 →
Q99PI5 0.997 Q99PI5 →
A6QP06 0.997 A6QP06 →
Q80TZ9 0.997 Q80TZ9 →
Q9VGA4 0.997 Q9VGA4 →
P70047 0.996 P70047 →
Q62901 0.996 Q62901 →
A0JMK9 0.996 A0JMK9 →
Q6E3D4 0.996 Q6E3D4 →
A0A5E4M3Q4 0.996 A0A5E4M3Q4 →
Q32KD2 0.995 Q32KD2 →
Q28Z18 0.995 Q28Z18 →
P97868 0.995 P97868 →
P06536 0.995 P06536 →
Q8C0I4 0.995 Q8C0I4 →
KMT5B Histone-lysine N-methyltransferase KMT5B 0.995 landscape →
Q24595 0.995 Q24595 →
Q1L8U8 0.995 Q1L8U8 →
Q8WML3 0.995 Q8WML3 →
Q9XTT4 0.995 Q9XTT4 →
P48193 0.995 P48193 →
Q6NN85 0.995 Q6NN85 →
P06537 0.994 P06537 →
Q8HXN7 0.994 Q8HXN7 →
Q17353 0.994 Q17353 →
Q86TC9 0.994 Q86TC9 →
Q5TKR9 0.994 Q5TKR9 →
Q9P2R6 0.994 Q9P2R6 →
Q7YZA2 0.994 Q7YZA2 →